You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

COVID-19 Resource Center

Healthcare professionals can find help and guidance on how to benefit from our offerings to treat your patients, as well as other practical information and advice.

Read more

News

ACQUISITION OF SHARES IN HUNTLEIGH TECHNOLOGY PLC

ACQUISITION OF SHARES IN HUNTLEIGH TECHNOLOGY PLC

Further to the announcement made on 8 December 2006 of a recommended cash offer by Getinge Extended Care UK Limited (the “Offeror”) (a wholly-owned subsidiary of Getinge AB (publ.)) for the acquisition of the entire issued and to be issued share capital of Huntleigh Technology PLC, including both the ‘A’ Ordinary Shares and the Ordinary Shares, the Offeror announces that it has acquired 15,516,717 ordinary shares in Huntleigh Technology PLC at a price of 480 pence per share. The total consideration paid for the stake was approximately £74.5 million. This acquisition has resulted in the Offeror holding approximately 18.19 per cent. of the existing issued share capital of Huntleigh.

For further information:
Ulf Grunander, Chief Financial Officer

Files

Share: